Ahren Innovation Capital

Ahren Innovation Capital is a deep tech and science-focused investment firm, aiming to support transformational companies at the intersection of cutting-edge science and technology. With over $400 million in their latest fund, Ahren targets companies working in domains such as AI, genetics, robotics, and sustainable energy. They take an active role in nurturing early-stage to pre-IPO companies, focusing on ventures that have the potential to create new markets or disrupt existing ones. Ahren’s portfolio includes pioneering companies like Graphcore (AI hardware), Edifice Health (inflammatory disease diagnostics), and Meatable (cultivated meat). Their science partners include Nobel laureates and renowned scientists like Sir Gregory Winter and Lord Martin Rees, who bring deep expertise to the diligence process and ongoing business support. The firm has a strong network of strategic LPs, giving their portfolio access to key industry partners and customers. Led by Alice Newcombe-Ellis, Ahren's model blends visionary investment with commercial acumen, helping companies scale while maintaining a commitment to groundbreaking innovation. They prioritize building lasting relationships with founders, positioning themselves as trusted partners who contribute both capital and deep technical knowledge​.